glp 1 for cardiovascular disease GLP-1 receptor agonists and outcome trials: An update Cardiovascular benefits of glucagon-like peptide-1

Reviewed submitted version of manuscript: Lemonick, Venigalla, Nguyen, Ezzat, Carr, Schupper, Slocum, Rosenblum, Tsankova

What lab tests should be monitored when taking BPC-157 with liver problems

Sodium Glucose Cotransport-2 Inhibition and Intrarenal RAS Activity in People With Type 1 Diabetes

sulfonylureas are often reduced or stopped

They may be able to switch you to a covered GLP1 for a different indication (e.g., prescribing Ozempic for diabetes instead of Wegovy for weight loss) or help you appeal a denial

Lauren Peizer, ND reviews your goals, symptoms, health history, and any relevant lab work to help determine whether this protocol makes sense for you